Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts

Daiichi Sankyo Company

Market Cap: JP¥6.9t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

PeptiDream

Market Cap: JP¥220.9b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Takara Bio

Market Cap: JP¥93.9b

Engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally.

Nxera Pharma

Market Cap: JP¥85.9b

Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥54.9b

A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.

Fuji Pharma

Market Cap: JP¥31.5b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

Japan Tissue Engineering

Market Cap: JP¥24.9b

Engages in the regenerative medicine business in Japan.

StemRIM

Market Cap: JP¥19.9b

A biotechnology company, develops regeneration medicines for the treatment of intractable diseases.

RaQualia Pharma

Market Cap: JP¥17.7b

Engages in the research and development of pharmaceutical compounds worldwide.

Kidswell Bio

Market Cap: JP¥9.7b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

Noile-Immune Biotech

Market Cap: JP¥7.4b

Researches and develops CAR-T cells for cancer immunotherapies.

TMS

Market Cap: JP¥6.7b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.